Earnings History Data for Intellia Therapeutics, Inc. (NTLA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Intellia Therapeutics, Inc.

Intellia Therapeutics is a leading genome editing company, focused on developing therapeutics utilizing a biological tool known as CRISPR-Cas9 system. It believes the CRISPR-Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific target deoxyribonucleic acid (DNA) sequence. The Company's sentinel in vivo programs focus on the use of Lipid Nanoparticle (LNPs) for delivery of the CRISPR/Cas9 complex to the liver. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR-Cas9 technology and create a new class of therapeutic pr...
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
22-02-2024 PM NTLA Intellia Therapeutics, Inc. 2,480 -1.46 -1.47 -1.40 Intellia Therapeutics GAAP EPS of -$1.46 misses by $0.03
[2/22/2024 7:33 AM]		 27.22 0.34 
(1.26%)		 26.90 0.02 
(0.07%)		 22.67 - 47.48 1,692,745 1,620,000 24,409
09-11-2023 PM NTLA Intellia Therapeutics, Inc. 2,610 -1.38 -1.52 -1.49 Intellia Therapeutics GAAP EPS of -$1.38 beats by $0.12, revenue of $12M beats by $0.05M
[11/9/2023 7:32 AM]		 24.96 -3.49 
(-12.27%)		 28.69 0.24 
(0.84%)		 22.81 - 57.49 2,691,989 1,700,000 3,480
03-08-2023 PM NTLA Intellia Therapeutics, Inc. 3,610 -1.40 -1.32 -1.33 Intellia Therapeutics GAAP EPS of -$1.40 misses by $0.09, revenue of $13.6M beats by $2.28M
[8/3/2023 7:32 AM]		 39.09 -0.62 
(-1.56%)		 39.09 0.0 
(0.00%)		 32.44 - 76.45 1,218,370 680,000 46,266
04-05-2023 PM 7:30 AM ET
(May 4)		 NTLA Intellia Therapeutics, Inc. 3,260 -1.17 -1.41 -1.96 Intellia Therapeutics GAAP EPS of -$1.17 beats by $0.21, revenue of $12.6M beats by $0.84M
[5/4/2023 7:32 AM]		 43.60 5.02 
(13.01%)		 39.50 0.92 
(2.38%)		 32.44 - 76.45 1,482,810 850,000 1,076
23-02-2023 PM 7:30 AM ET
(Feb 23)		 NTLA Intellia Therapeutics, Inc. 3,480 -1.40 -1.40 -1.09 Intellia Therapeutics GAAP EPS of -$1.40 misses by $0.04, revenue of $13.6M beats by $2.89M
[2/23/2023 7:32 AM]		 38.84 -0.10 
(-0.26%)		 40.00 1.06 
(2.72%)		 32.44 - 103.06 841,966 970,000 1,666
03-11-2022 PM 7:30 AM ET
(Nov 3)		 NTLA Intellia Therapeutics, Inc. 4,040 -1.49 -1.31 -0.97 Intellia Therapeutics GAAP EPS of -$1.49 misses by $0.21, revenue of $13.27M beats by $2.43M
[11/3/2022 7:32 AM]		 51.85 0.75 
(1.47%)		 51.41 0.31 
(0.61%)		 37.08 - 143.92 529,841 850,000 611
04-08-2022 PM 7:30 AM ET
(Aug 4)		 NTLA Intellia Therapeutics, Inc. 4,940 -1.33 -1.30 -1.01 Intellia Therapeutics GAAP EPS of -$1.33 misses by $0.02, revenue of $14.03M beats by $4.53M
[8/4/2022 7:36 AM]		 65.38 -6.32 
(-8.82%)		 3.92 -0.40 
(-9.26%)		 37.08 - 180.59 2,623,016 1,020,000 51,552
05-05-2022 PM 7:30 AM ET
(May 5)		 NTLA Intellia Therapeutics, Inc. 3,850 -1.96 -1.11 -0.69 Intellia Therapeutics GAAP EPS of -$1.96 misses by $0.86, revenue of $11.25M beats by $2.68M
[5/5/2022 7:32 AM]		 49.81 -5.89 
(-10.57%)		 56.25 0.55 
(0.99%)		 47.02 - 202.73 1,294,279 1,120,944 18,919
24-02-2022 PM 7:30 AM ET
(Feb 24)		 NTLA Intellia Therapeutics, Inc. 6,270 -1.09 -0.91 -0.69 Intellia Therapeutics GAAP EPS of -$1.09 misses by $0.15, revenue of $12.85M beats by $5.02M
[2/24/2022 7:35 AM]		 86.76 6.71 
(8.39%)		 0.0 0.0 
(0.00%)		 43.86 - 202.73 1,526,795 918,881 0
04-11-2021 PM 7:30 AM ET
(Nov 4)		 NTLA Intellia Therapeutics, Inc. 10,030 -0.97 -0.85 -0.47 Intellia Therapeutics EPS misses by $0.11, misses on revenue
[11/4/2021 7:32 AM]		 134.04 -1.86 
(-1.37%)		 133.94 -0.10 
(-0.08%)		 25.50 - 202.73 611,202 570,000 28,631
05-08-2021 PM 7:30 AM ET
(Aug 5)		 NTLA Intellia Therapeutics, Inc. 10,250 -1.01 -0.61 -0.61 Intellia Therapeutics EPS misses by $0.38, misses on revenue
[8/5/2021 7:32 AM]		 165.31 18.37 
(12.50%)		 143.21 -3.73 
(-2.54%)		 16.54 - 202.73 3,484,517 960,000 4,292
06-05-2021 PM 7:30 AM ET
(May 6)		 NTLA Intellia Therapeutics, Inc. 5,030 -0.69 -0.66 -0.63 Intellia Therapeutics EPS misses by $0.04, misses on revenue
[5/6/2021 7:31 AM]		 66.48 -4.88 
(-6.84%)		 66.48 0.0 
(0.00%)		 12.51 - 92.00 1,899,338 1,130,000 1,060
25-02-2021 PM 7:30 AM ET
(Feb 25)		 NTLA Intellia Therapeutics, Inc. 4,670 -0.69 -0.57 -0.57 Intellia Therapeutics EPS misses by $0.09, misses on revenue
[2/25/2021 7:31 AM]		 57.33 -6.39 
(-10.03%)		 62.00 -1.72 
(-2.70%)		 9.18 - 92.00 1,922,299 1,277,870 12,615
05-11-2020 PM 7:30 AM ET
(Nov 5)		 NTLA Intellia Therapeutics, Inc. 1,480 -0.47 -0.54 -0.49 Intellia Therapeutics EPS beats by $0.10, beats on revenue
[11/5/2020 7:33 AM]		 28.48 1.31 
(4.82%)		 28.48 0.0 
(0.00%)		 9.18 - 30.43 1,534,171 802,419 212,089
06-08-2020 PM 7:30 AM ET
(Aug 6)		 NTLA Intellia Therapeutics, Inc. 1,130 -0.61 -0.69 -0.56 Intellia Therapeutics EPS beats by $0.09, beats on revenue
[8/6/2020 7:35 AM]		 20.89 1.24 
(6.31%)		 20.84 1.19 
(6.05%)		 9.18 - 25.56 570,082 631,462 4,640